GLP-1 Drugs and Addiction GLP-1 receptor agonists were originally developed to help manage type 2 diabetes, but their popularity has surged in recent years because of their effectiveness for weight loss
Semaglutide (Wegovy, Ozempic) aims at one receptor (GLP-1), while tirzepatide (Zepbound, Mounjaro) homes in on two (GLP-1 and GIP)
van Kemenade, P
You can take injectable semaglutide at any time of the day without regard to meals
At MATTR, every client undergoes a comprehensive medical consultation to ensure safety, appropriateness, and a personalized treatment plan
Pros Highest bioavailability of all forms Direct action on injured or inflamed tissues Proven effectiveness in animal and veterinary studies Flexible dosing and stacking with other peptides (e.g., TB500) Cons Requires injections (daily or every other day) Must be mixed and stored properly (cold chain sensitive) Higher cost compared to capsules or oral sprays May require sterile technique and user experience Best For Athletes and bodybuilders recovering from joint, tendon, or muscle injuries Post-surgical healing and performance-focused rehab For full cycle and dosing strategies, refer to: BPC157 Cycle Guide Oral BPC157 (Liquid Solutions) Oral BPC157 in liquid form typically delivered as a sublingual dropper or liquid swallowed directly is marketed as a gut-targeted version of the peptide